[1] 中华人民共和国卫生部.医院感染诊断标准(试行)[J].中华医学杂志,2001,81(5):314-320. [2] MATOS T, LEJKO ZUPANC T, SKOFIJANEC A, et al. Candidaemia in Central Slovenia:A 12-year retrospective survey[J]. Mycoses,2021,64(7):753-762. [3] PAPPAS P G, LIONAKIS M S, ARENDRUP M C, et al. Invasive candidiasis[J]. Nat Rev Dis Primers,2018,4:18026. DOI:10.1038/nrdp.2018.26. [4] XIAO M, SUN Z Y, KANG M, et al. Five-year national surveillance of invasive candidiasis:species distribution and azole susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study[J]. J Clin Microbiol,2018,56(7):e00577-18. [5] 俞娟芬,张亚峰,张建国,等.真菌血流感染病原学与临床特点及其预后危险因素[J].中华医院感染学杂志,2022,32(6):852-856. [6] 井然,侯欣,肖盟,等.中国侵袭性真菌耐药监测网成员单位重症监护室侵袭性酵母的布特征及其对三唑类药物敏感性的变迁[J].中国感染与化疗杂志,2020,20(2):175-180. [7] PFALLER M A, DIEKEMA D J, TURNIDG J D, et al. Twenty years of the SENTRY antifungal surveillance program:Results for Candida species from 1997-2016[J]. Open Forum Infect Dis, 2019,6(Suppl 1):S79-S94. [8] 刘云,黄晓春,万玉香,等.临床真菌血流感染的菌株分布及耐药性分析[J].现代检验医学杂志,2018,33(04):81-82,86. [9] 陈霞,杨勇文,李艳明,等.ICU念珠菌血流感染患者的临床特点及死亡的危险因素[J].中南大学学报(医学版),2021,46(7):719-724. [10] 黄廷廷,夏文颖,许雨乔,等.真菌血流感染患者死亡率相关危险因素分析[J].中国感染与化疗杂志,2020,20(5):465-469. [11] 张文,罗莹,国承杰,等.院内念珠菌血症临床特点及病原菌分析[J].中国真菌学杂志,2020,15(3):154-160. [12] SCHROEDER M, WEBER T, DENKER T, et al. Epidemiology, clinical characteristics, and outcome of candidemia in critically ill patients in Germany:a single-center retrospective 10-year analysis[J]. Ann Intensive Care,2020,10(1):142. [13] 朱玲.念珠菌血流感染流行病学特征及病死率危险因素分析[D].上海交通大学,2016. [14] MUDERRIS T, KAYA S, ORMEN B, et al. Mortality and risk factor analysis for Candida blood stream infection:A three-year retrospective study[J]. J Mycol Med,2020,30(3):101008. [15] KATO H, YOSHIMURA Y, SUIDO Y, S et al. Mortality and risk factor analysis for Candida blood stream infection:A multicenter study[J]. J Infect Chemother,2019,25(5):341-345. |